首页> 外文期刊>Journal of infection prevention >Evaluation of the clinical performance of a chlorhexidine gluconate antimicrobial transparent dressing
【24h】

Evaluation of the clinical performance of a chlorhexidine gluconate antimicrobial transparent dressing

机译:葡萄糖酸氯己定抗菌透明敷料的临床性能评估

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Each year, an estimated 250,000 cases of central line associated bloodstream infections occur in hospitals in the United States (CDC, 2005). Reduction of CRBSI has become a major focus for education and initiatives to improve practice. Various antimicrobial agents and practices are supported with evidence to demonstrate impact on CRBSI. The broad spectrum activity of chlorhexidine as an antibacterial, antiviral, and antifungal agent is weil accepted (Denton, 2001).The purpose of this clinical evaluation was to statistically validate the performance of a new chlorhexidine gluconate (CHG) gel dressing. A fully integrated transparent dressing with a CHG gel pad was evaluated in six different facilities across the United States over a period of 73 days with 64 different clinicians. A total of 500 CHG gel dressings were applied during the evaluation period. The clinicians were asked to evaluate 16 levels of performance criteria of the new CHG gel dressings and compare these areas of performance to the performance of their current CHG disk plus transparent dressing being used at their facility. Their current dressing was replaced with the new CHG gel dressing. All sites changed dressings at 24-48 hours as needed, and then at seven days. The evaluation questions were striated into four performance groups: ease of application, gel dressing performance, securement function and 'other'. In all 16 levels of performance ratings, the CHG gel dressing was rated 'same as', 'better', or 'much better'. In addition to the antimicrobial advantages of a CHG gel dressing, clinical data demonstrates the following benefits: ease of use of a one piece CHG gel dressing, ability to fully visualise the insertion site through the gel, and absorption of fluid under the dressing. The new CHG gel dressing was well tolerated by patients and performed in a manner that equalled or well exceeded the current two step process of antimicrobial dressing application.
机译:每年,在美国的医院中估计有250,000例中枢线相关的血液感染病例(CDC,2005)。降低CRBSI已成为教育和改善实践的主要重点。各种抗微生物剂和实践均得到支持,以证明对CRBSI的影响。氯己定作为抗菌,抗病毒和抗真菌剂的广谱活性已被威尔接受(Denton,2001年)。该临床评估的目的是从统计学上验证新型葡萄糖酸氯己定(CHG)凝胶敷料的性能。在73天的时间里,与64位不同的临床医生一起在美国的六个不同机构中对带有CHG凝胶垫的完全集成的透明敷料进行了评估。在评估期间,总共使用了500 CHG凝胶敷料。要求临床医生评估新CHG凝胶敷料的16个性能标准水平,并将这些性能领域与他们当前使用的CHG圆盘加透明敷料的性能进行比较。他们目前的敷料被新的CHG凝胶敷料取代。所有站点都根据需要在24-48小时,然后在7天更换敷料。评估问题分为四个性能组:易用性,凝胶敷料性能,固定功能和“其他”。在所有16个性能等级中,CHG凝胶敷料的等级为“相同”,“更好”或“好得多”。除了CHG凝胶敷料的抗微生物优势外,临床数据还显示出以下好处:一件式CHG凝胶敷料的易用性,通过凝胶完全显现插入部位的能力以及在敷料下吸收液体的能力。新的CHG凝胶敷料对患者具有良好的耐受性,并且以与目前的两步抗菌敷料过程相同或远远超过目前的方式进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号